INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $280,000 | -80.4% | 26,700 | -70.2% | 0.01% | -64.0% |
| Q1 2016 | $1,431,000 | +46.8% | 89,461 | +162.5% | 0.02% | +150.0% |
| Q4 2015 | $975,000 | +55.0% | 34,081 | +128.5% | 0.01% | +150.0% |
| Q4 2014 | $629,000 | +109.7% | 14,916 | +93.3% | 0.00% | +300.0% |
| Q3 2014 | $300,000 | – | 7,716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,359,247 | $79,013,000 | 7.20% |
| JW Asset Management, LLC | 187,118 | $10,877,000 | 4.70% |
| Opaleye Management Inc. | 110,000 | $6,394,000 | 2.97% |
| Timpani Capital Management LLC | 97,919 | $5,692,000 | 1.70% |
| JUNCTURE WEALTH STRATEGIES, LLC | 14,139 | $822,000 | 0.68% |
| Orbimed Advisors | 1,243,200 | $72,267,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $5,813,000 | 0.60% |
| NEXT CENTURY GROWTH INVESTORS LLC | 273,594 | $15,904,000 | 0.56% |
| B. Riley Wealth Management, Inc. | 7,550 | $438,000 | 0.33% |
| GARGOYLE INVESTMENT ADVISOR L.L.C. | 11,131 | $647,000 | 0.24% |